about
Functionally biased modulation of A(3) adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancersDefining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer.Multiple binding sites for small-molecule antagonists at the CC chemokine receptor 2.Trastuzumab and pertuzumab produce changes in morphology and estrogen receptor signaling in ovarian cancer xenografts revealing new treatment strategies.A series of 2,4-disubstituted quinolines as a new class of allosteric enhancers of the adenosine A3 receptor.False positives in a reporter gene assay: identification and synthesis of substituted N-pyridin-2-ylbenzamides as competitive inhibitors of firefly luciferase.
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Annelien Zweemer
@ast
Annelien Zweemer
@en
Annelien Zweemer
@es
Annelien Zweemer
@nl
type
label
Annelien Zweemer
@ast
Annelien Zweemer
@en
Annelien Zweemer
@es
Annelien Zweemer
@nl
altLabel
A. Zweemer
@nl
prefLabel
Annelien Zweemer
@ast
Annelien Zweemer
@en
Annelien Zweemer
@es
Annelien Zweemer
@nl
P108
P106
P31
P496
0000-0002-3539-3129
P7449
PRS1340641